JPMorgan Downgrades Accelerate Diagnostics (AXDX) to Underweight

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY

6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Price: $0.03 --0%

Rating Summary:
2 Buy, 2 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0

JPMorgan analyst Tycho Peterson downgraded Accelerate Diagnostics (NASDAQ: AXDX) from Neutral to Underweight with a price target of $16.00.

Steps aside following disappointing results released from highly-anticipated Mayo/UCLA study.
Believes "ambitious" guidance for FY generates a significant burden and risk on the NT outlook.
Sees better risk/reward offering elsewhere in coverage universe.

For an analyst ratings summary and ratings history on Accelerate Diagnostics click here. For more ratings news on Accelerate Diagnostics click here.

Shares of Accelerate Diagnostics closed at $20.64 yesterday.

JPMorgan

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!